1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy see


Versions (2) ▾
  1. 11/22/11
  2. 3/25/14
Uploaded on:

March 25, 2014

No DOI assigned. To request one please log in.
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00153023 Type 2 diabetes mellitus

Eligibility Hypertension and Diabetes NCT00153023

Inclusion Criteria
30 to 80 Years
Type 2 diabetes mellitus
Hypertension at screening defined as: an average cuff systolic blood pressure > 130 mmHg and/or diastolic blood pressure >80 mmHg in untreated patients OR patients receiving antihypertensive therapy (i.e., medications specifically prescribed to treat hypertension)
Overt nephropathy defined by 24 hour proteinuria >= 900 mg and by serum creatinine below 265 mol/l (3.0 mg/dl)

Similar models